In Silico Screening of Effective Inhibitor of 5α-Reductase Type 1 for Androgenic Alopecia Treatment
December 2021
in “
Natural Product Research
”
Studysummary In this study, in silico screening and molecular simulations identified β-sitosterol and brassicasterol as stable potential inhibitors of 5α-reductase1, suggesting they could be explored for androgenic alopecia treatment.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study focuses on identifying potential inhibitors of 5α-reductase type 1, an enzyme linked to androgenic alopecia, through in silico screening of 110 phytochemicals. The research highlights β-sitosterol, brassicasterol, and campesterol as promising candidates due to their potential to inhibit 5α-reductase1. Molecular dynamics simulations indicated that β-sitosterol and brassicasterol complexes exhibit stability, suggesting their potential as lead compounds in developing treatments for androgenic alopecia.
